Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriers

Georgetti, 2008, Evaluation of in vivo efficacy of topical formulations containing soybean extract, Int. J. Pharm., 352, 189, 10.1016/j.ijpharm.2007.10.037 Bouwstra, 2002, Skin structure and mode of action of vesicles, Adv. Drug Deliv. Rev., 54, S41, 10.1016/S0169-409X(02)00114-X Cevc, 2004, Lipid vesicles and other colloids as drug carriers on the skin, Adv. Drug Deliv. Rev., 56, 675, 10.1016/j.addr.2003.10.028 Prausnitz, 2004, Current status and future potential of transdermal drug delivery, Nat. Rev. Drug Discov., 3, 115, 10.1038/nrd1304 Heurtault, 2002, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharm. Res., 19, 875, 10.1023/A:1016121319668 Lamprecht, 2002, New lipid nanocapsules exhibit sustained release properties for amiodarone, J. Controlled Release, 84, 59, 10.1016/S0168-3659(02)00258-4 Lamprecht, 2004, Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment, Int. J. Pharm., 278, 407, 10.1016/j.ijpharm.2004.03.018 Peltier, 2006, Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules, Pharm. Res., 23, 1243, 10.1007/s11095-006-0022-2 Allard, 2008, Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, J. Controlled Release, 130, 146, 10.1016/j.jconrel.2008.05.027 Béduneau, 2008, Brain targeting using novel lipid nanovectors, J. Controlled Release, 126, 44, 10.1016/j.jconrel.2007.11.001 Khalid, 2006, Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors, Pharm. Res., 23, 752, 10.1007/s11095-006-9662-5 Lamprecht, 2006, Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition, J. Controlled Release, 112, 208, 10.1016/j.jconrel.2006.02.014 Beduneau, 2007, Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab’ fragments, Biomaterials, 28, 4978, 10.1016/j.biomaterials.2007.05.014 Anton, 2009, Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules, Langmuir, 25, 11413, 10.1021/la901565q Schäfer-Korting, 2007, Lipid nanoparticles for improved topical application of drugs for skin diseases, Adv. Drug Deliv. Rev., 59, 427, 10.1016/j.addr.2007.04.006 Müller, 2007, Nanostructured lipid carriers (NLC) in cosmetic dermal products, Adv. Drug Deliv. Rev., 59, 522, 10.1016/j.addr.2007.04.012 Radomska-Soukharev, 2007, Stability of lipid excipients in solid lipid nanoparticles, Adv. Drug Deliv. Rev., 59, 411, 10.1016/j.addr.2007.04.004 Casadei, 2006, Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations, Int. J. Pharm., 325, 140, 10.1016/j.ijpharm.2006.06.012 Li, 2008, A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers, Int. J. Pharm., 363, 177, 10.1016/j.ijpharm.2008.07.017 Jacobi, 2005, Comparison of four different in vitro systems to study the reservoir capacity of the stratum corneum, J. Controlled Release, 103, 61, 10.1016/j.jconrel.2004.11.013 Simon, 2000, The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations—an overview, Skin Pharmacol. Appl. Skin Physiol., 13, 229, 10.1159/000029928 Benech-Kieffer, 2000, Percutaneous absorption of sunscreens in vitro: interspecies comparison, skin models and reproducibility aspects, Skin Pharmacol. Appl. Skin Physiol., 13, 324, 10.1159/000029940 Schmook, 2001, Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption, Int. J. Pharm., 215, 51, 10.1016/S0378-5173(00)00665-7 Hadgraft, 2000, pH, pKa and dermal delivery, Int. J. Pharm., 200, 243, 10.1016/S0378-5173(00)00402-6 Shokri, 2001, The effect of surfactants on the skin penetration of diazepam, Int. J. Pharm., 228, 99, 10.1016/S0378-5173(01)00805-5 Benson, 2005, Transdermal drug delivery: penetration enhancement techniques, Curr. Drug Deliv., 2, 23, 10.2174/1567201052772915 Zhao, 2009, A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ, Eur. J. Pharm. Biopharm., 72, 521, 10.1016/j.ejpb.2009.03.002 Zhai, 2001, Effects of skin occlusion on percutaneous absorption: an overview, Skin Pharmacol. Appl., 14, 1, 10.1159/000056328 Zellmer, 1995, Interaction of phosphatidylcholine liposomes with the human stratum corneum, Biochim. Biophys. Acta, 237, 176, 10.1016/0005-2736(95)00100-H Sinico, 2005, Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction, J. Controlled Release, 103, 123, 10.1016/j.jconrel.2004.11.020 Moser, 2001, Enhanced skin permeation of a lipophilic drug using supersaturated formulations, J. Controlled Release, 73, 245, 10.1016/S0168-3659(01)00290-5 Wu, 2009, Drug delivery to the skin from sub-micron polymeric particle formulations: influence of particle size and polymer hydrophobicity, Pharm. Res., 26, 1995, 10.1007/s11095-009-9915-1 Cleek, 1993, A new method for estimating dermal absorption from chemical exposure. 1. General approach, Pharm. Res., 10, 497, 10.1023/A:1018981515480